CAMBRIDGE, Mass. and DUBLIN, Ireland, Oct. 30, 2019 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) approved Vumerity (diroximel fumarate), a novel oral…Original Article
FDA Approves Vumerity (diroximel fumarate) for Multiple Sclerosis
